In 2023, the consumption of Alimentary Tract and Metabolism medicine in Denmark was at a certain level, and this usage is projected to grow. From 2024 to 2028, the defined daily dosage per thousand persons per day shows a consistent upwards trend:
- From 2023 to 2024: 215.8
- From 2024 to 2025: 2.0% increase
- From 2025 to 2026: 2.0% increase
- From 2026 to 2027: 2.0% increase
- From 2027 to 2028: 1.9% increase
The Compound Annual Growth Rate (CAGR) over the five-year period from 2024 to 2028 reflects a steady average annual growth rate of approximately 2%. This consistent increase suggests a rising need and utilization of these medications in the Danish population.
Future trends to monitor include the evolution of healthcare policies, advancements in medical treatments related to the alimentary tract and metabolism, and demographic changes such as aging populations which may further influence the demand for these medications. Additionally, the impact of healthcare innovations and digital health monitoring systems may reveal new patterns in medication usage.
